These discordant findings between EpAT and ThAT suggest that PPAR-γ/adiponectin signaling in EpAT is controlled by local mechanisms, possibly originating in the heart, rather than by systemic effects related to obesity and insulin resistance. This evidence concerns the gene PPARG and obesity due to melanocortin 4 receptor deficiency.